Understanding FDA not Cleared for Post-Concussion Syndrome

banner image

Post-Concussion Syndrome (PCS) is the persistence of symptoms long after a mild traumatic brain injury (TBI), or concussion. 


Unlike symptoms from a structural brain injury, PCS is believed to be a functional neurological disorder resulting from a complex "neurometabolic cascade" that disrupts the brain's delicate balance.


The balance between excitatory and inhibitory neural activity is disrupted.


Concussion can lead to a state of decreased neuronal excitability and impaired neurotransmission, which may compromise the brain's ability to form new connections.  

The brain's natural capacity to reorganize itself after injury is hindered, leading to chronic symptoms in cognitive function, emotional regulation, and pain processing.


However, a highly relevant article that discusses Deep TMS for Post-Concussion Syndrome is       https://www.sciencedirect.com/science/article/abs/pii/S0278584623001495



Deep Transcranial Magnetic Stimulation (Deep TMS) is being researched for its ability to target and modulate the specific brain circuits affected by PCS. 


Unlike traditional TMS, Deep TMS, with its patented H-Coil technology, is capable of stimulating broader and deeper brain regions, which may be crucial for affecting the complex, diffuse network disruptions common in PCS.


When applied in a specific repetitive pattern, Deep TMS can induce long-term changes in synaptic strength, a process known as Long-Term Potentiation (LTP) or Long-Term Depression (LTD), depending on the stimulation frequency. 


This can be understood as "retraining" the brain to communicate more effectively.


Clinical studies on the use of  Deep TMS for PCS have shown compelling results, including a "delayed response" where significant improvements in symptom burden were found months after the treatment ended. 


Indicating that the therapy may be aiding in the brain's long-term recovery and neuroplastic changes, rather than simply providing immediate, temporary relief. 



Left Dorsolateral Prefrontal Cortex (DLPFC) 

This region is a primary target for improving mood and cognitive functions such as working memory, attention, and executive function. 


High-frequency stimulation of the DLPFC is hypothesized to increase cortical excitability and brain activation, which may help restore these critical functions.



Neurotransmitter Modulation

Deep TMS is believed to orchestrate the release of key neurotransmitters like dopamine and glutamate, which are essential for mood, motivation, and cognitive processing and are often dysregulated after TBI.




In Summary

PCS presents a unique challenge in neuromedicine, but the technical capabilities of Deep TMS offer a promising, non-invasive avenue for research and treatment. 


By modulating the neuroplasticity and cortical excitability that are fundamentally altered by concussion, Deep TMS aims to move beyond symptom management and toward a functional restoration of brain networks.

  

Curious about How BrainsWay Deep TMS® could transform your Health?

BrainsWay Deep TMS® offers innovative approaches not only for neurological and psychiatric conditions. 


Important disclaimer

BrainsWay Deep TMS® Treatment for Post-Concussion Syndrome is not intended for individuals in the United States as it HAS NOT BEEN FULLY CLEARED by the FDA for safety and efficacy for these specific indications. 


 "It is important to note that while these specific indications may not be FDA-cleared in the United States, some BrainsWay Deep TMS® treatments for certain conditions may have received CE Mark approval in Europe, indicating compliance with European health, safety, and environmental protection standards. Always verify the regulatory status of any treatment in your specific region."